| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 12.196 | 14.192 | 12.849 | 26.098 | 21.763 | 12.183 |
| Total Income - EUR | - | - | - | 0 | 12.196 | 14.192 | 12.849 | 26.098 | 21.770 | 12.218 |
| Total Expenses - EUR | - | - | - | 6.593 | 8.313 | 9.885 | 21.934 | 25.677 | 33.770 | 35.078 |
| Gross Profit/Loss - EUR | - | - | - | -6.593 | 3.884 | 4.308 | -9.085 | 422 | -12.000 | -22.860 |
| Net Profit/Loss - EUR | - | - | - | -6.593 | 3.754 | 4.166 | -9.470 | -157 | -12.218 | -22.982 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Eso-Gin Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 27.481 | 26.949 | 26.438 | 57.264 | 43.053 | 28.576 | 16.687 |
| Current Assets | - | - | - | 456 | 13.924 | 13.813 | 7.320 | 17.147 | 22.693 | 8.120 |
| Inventories | - | - | - | 403 | 0 | 0 | 0 | 0 | 64 | 63 |
| Receivables | - | - | - | 11 | 12.644 | 13.044 | 0 | 3.103 | 25 | 16 |
| Cash | - | - | - | 43 | 1.280 | 769 | 7.320 | 14.045 | 22.604 | 8.040 |
| Shareholders Funds | - | - | - | -6.550 | 733 | 4.885 | -12.386 | -12.581 | -24.760 | -47.604 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 34.487 | 40.140 | 35.366 | 76.971 | 72.781 | 76.029 | 72.411 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
9609
|
|||||||||
Comments - Eso-Gin Med S.r.l.